---
title: "Cholic acid - Cerebrotendinous xanthomatosis"
sidebar: mydoc_sidebar
permalink: db02659-mesh-d019294-1.html
toc: false 
---


Path ID: `DB02659_MESH_D019294_1`
{% include image.html url="images/db02659-mesh-d019294-1.png" file="db02659-mesh-d019294-1.png" alt="db02659-mesh-d019294-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019826 | cholic acid | Drug |
| GO:0047749 | sterol 27-hydroxylase activity | MolecularActivity |
| MESH:D019294 | Cerebrotendinous Xanthomatosis | Disease |
| MESH:D004083 | Cholestanol | ChemicalSubstance |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cholic Acid | PRODUCED BY | Sterol 27-Hydroxylase Activity |
| Sterol 27-Hydroxylase Activity | NEGATIVELY CORRELATED WITH | Cerebrotendinous Xanthomatosis |
| Sterol 27-Hydroxylase Activity | DECREASES ABUNDANCE OF | Cholestanol |
| Cholestanol | CONTRIBUTES TO | Cerebrotendinous Xanthomatosis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB02659#mechanism-of-action](https://go.drugbank.com/drugs/DB02659#mechanism-of-action){:target="_blank"}